TransCode Therapeutics RNAZ
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 10.75 | 94.04 | -2.04 | -4,561 | -5 | |
| 2025Q2 | 7.80 | 98.71 | -5.13 | -4,221 | -4 | |
| 2025Q1 | 13.86 | 26.24 | -70.29 | -3,171 | -12 | |
| 2024Q4 | 94.36 | 86.10 | -202.19 | -5,092 | -6 | |
| 2024Q3 | 527.60 | 93.72 | 173.05 | -2,165 | -2 | |
| 2024Q2 | 928.62 | 98.61 | -696.01 | -5,114 | -5 | |
| 2024Q1 | 631.09 | 99.16 | -597.87 | -3,289 | -3 | |
| 2023Q4 | 6091.01 | 100.66 | 157173.71 | -4,098 | -4 | |
| 2023Q3 | 18579.79 | 100.53 | 91948.99 | -5,349 | -5 | |
| 2023Q2 | 85008.00 | 118.12 | -105433.11 | -5,144 | -4 | |
| 2023Q1 | 250219.20 | 101.74 | -239433.35 | -4,901 | -5 | |
| 2022Q4 | 497481.60 | 107.65 | -292356.23 | -5,527 | -5 | |
| 2022Q3 | 813120.00 | 115.48 | -244307.80 | -4,954 | -4 | |
| 2022Q2 | 931392.00 | 100.77 | -264266.38 | -4,707 | -5 | |
| 2022Q1 | 2128896.00 | 100.20 | -199627.92 | -3,478 | -3 | |
| 2021Q4 | 1877568.00 | 106.68 | -170017.53 | -2,986 | -3 | |
| 2021Q3 | 2210208.00 | 101.33 | -155233.40 | -2,360 | -2 | |
| 2021Q2 | -12.66 | 443523.99 | -356 | 3 | ||
| 2021Q1 | 10.13 | -717030.45 | -449 | -4 | ||
| 2020Q4 | -379 | -1 |